Partnership Opportunities
Are you Looking to Position Yourself as a Leader in the Complement-Based Development Field?
The 9th Complement-Based Drug Development Summit returns to Boston December 1-3, 2025, bringing together 80+ drug developers from established pharma and emerging biotechs including Apellis, Sanofi, Annexon and many more. This exclusive event is designed to tackle the industry's toughest challenges and bottlenecks in complement-mediator development head-on.
Maximize your brand's impact in 2025. Partner with us for unparalleled, direct access to the key companies developing ground-breaking complement inhibitors.
Top solutions needed:
1
Immunoassays for diagnostics, monitoring complement levels and toxicology studies
2
Reagent providers for discovery and preclinical studies
3
Selective and specific antibody providers for complement biology
4
Humanized complement models to reduce translational hurdles for complement therapeutics
Why Partner?
Showcase your brand to boost awareness in the complement and immune modulation space and increase your market share through onsite and preconference marketing strategies
Connect with the key decision-makers to gain their trust in your services by presenting your innovative services in the main agenda to help them achieve clinical success
Generate new business leads with the competitive intelligence on complement-based drug development available at this niche and focussed meeting to help you reach your 2025 commercial goals
Understand the challenges of the experts in the field to help tailor your solutions to the needs of the industry
Contribute to the rapidly advancing field to bring the next generation of complement-based therapeutics to patients across hematology, ophthalmology, nephrology, oncology and more
Who Will You Meet?
